The company held the 7th meeting of the 11th board of directors and the 7th meeting of the 10th board of supervisors to review and approve the annual work report and other related proposals
Release time:
2022-05-05
News from our newspaper # February 16 , Chairman Jiang Xiaomeng of the Group Company presided over the meeting of the 11th Board of Directors of the Company, it reviewed and approved 17 related reports and proposals such as 2021 annual board of directors report, 2021 annual general manager business report, 2021 annual report, 2021 annual financial final accounts report, 2021 annual profit distribution plan, etc.
General Manager's report pointed out that 2021 is the first year of the national "14th Five-Year Plan" , The management team, according to the company's five-year development plan and the annual management plan approved by the board of directors, focuses on the general working policy of "following the rules, keeping the right and bringing forth new ideas, reforming and innovating, and continuously improving, calmly deal with the new coronary pneumonia epidemic, raw material prices ups and downs, production restrictions and power restrictions and many other challenges, better to complete the work objectives set at the beginning of the year. As of the end of 2021 , the company's total assets were 70.24 .9 billion yuan, up 10.74% year-on-year, and the net assets attributable to shareholders of listed companies were 52.07 .3 billion yuan, up 17.39% year-on-year. For the whole year, operating income reached 38.05 .7 billion yuan, up 17.17% year-on-year, net profit attributable to shareholders reached 9.24 .1 billion yuan, up 58.12% year-on-year, and operating performance reached the best level in history.
2021, the company's cement plate industry chain extension war made new progress, holding the establishment of Hubei peak new building materials Co., Ltd., orderly promote the mechanism of sand project. Actively participated in the major asset restructuring of Tianshan shares and achieved good investment returns. All cement enterprises under the company continue to implement benchmarking management and fine management, carry out in-depth "three reductions and three improvements" activities, steadily implement various technological transformation work, strictly control production costs, and continuously improve the operation efficiency of enterprises. A total of cement clinker ,675 tons were sold throughout the year, up 28% year on year. Daye Peak manages the procurement of raw materials through multi-channel, open and transparent, and full supervision, and strictly controls the procurement cost while ensuring the quality. Continuously optimize the batching scheme, complete the technical transformation of the automatic batching system, increase the proportion of limestone in raw materials, and reduce the cost of raw materials; Continuously optimize the process parameters and use the MES system to trace the optimal parameters, combined with the implementation of more than ten technical transformations such as low-nitrogen combustion at the kiln end and dust collection system at the kiln end, the stability of the equipment has been improved, the overall production capacity of the kiln system has been improved, and the annual cement output has reached the best level in history. Yunnan Jianfeng strictly controls the procurement cost of raw materials by strengthening bidding management. Through the technical renovation of grate cooler, preheater and other equipment, the output of rotary kiln has been effectively increased. Affected by the completion of some key projects in the region and the commissioning of new cement production capacity, the competition in the cement market in this region has intensified and the price has dropped greatly. Therefore, the company further strengthened the regional market segmentation work according to market changes in time and formulated differentiated marketing strategies for different market segments, basically maintain the balance of production and sales. 2021 is the first complete year after Guizhou Jianfeng was put into production. Guizhou Jianfeng relies on the advanced second-generation new dry-process cement production line and adopts digital intelligent control technology to realize all-round intelligent management such as safe production, product quality, material consumption and energy consumption. Strengthen operator training, improve skill level, timely adjust and optimize process parameters, and ensure product quality stability; The whole line has reached the standard and reached the production capacity, coal consumption, electricity consumption, operation rate, kiln production, labor productivity and other indicators reached a good level.
2021, the company made progress in a number of technological innovations and engineering constructions in the pharmaceutical sector. The construction of the annual production of 20 .9 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical Co., Ltd. is progressing in an orderly manner. At present, the civil engineering and equipment installation and commissioning of the project have been basically completed, and the preliminary preparations for project acceptance and application for certification of cGMP are underway; new North Card and Peak North Card continue to implement comprehensive technological transformation, and intend to upgrade on the basis of existing pesticides and pharmaceutical intermediates, build a comprehensive research and development and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of APIs and preparations in the pharmaceutical sector of the company. Jianfeng Pharmaceutical and its subsidiaries further increased their investment in research and development and completed the registration of moxifloxacin hydrochloride eye drops, lenvatinib mesylate capsules, valsartan amlodipine tablets and esomeprazole magnesium enteric-coated dry suspension 4 drugs. Peak pharmaceutical products won the bid for the first time in the national drug centralized procurement, olopatadine hydrochloride eye drops won the bid for the fourth batch of national drug centralized procurement, which is conducive to the market promotion of the product, sales have been greatly improved.
In addition, Jianfeng Health has completed the research and development of health food such as coenzyme Q10 soft capsule and broken ganoderma lucidum spore powder, and has obtained the record. Completed the development of many functional foods such as vitality V5 liquid drink and collagen liquid drink, and has now listed 6 ; "Development and Industrialization of Wall-broken Ganoderma lucidum Spore Powder for Enhancing Immunity" was approved by Jinhua Municipal Technology Innovation Project in 2021 . "Cranberry Extract" won the project of key high-tech products in Zhejiang Province in 2021 . Peak cable carried out the subway communication cable "Zhejiang manufacturing" standard construction work, high-speed data transmission with twisted pair communication cable through the "Zhejiang manufacturing" certification, won the representative of Zhejiang manufacturing benchmark "word mark". According to the development trend of regional trade and logistics, combined with the characteristics of the enterprise itself, Jianfeng International Trade has continuously improved its business development model and promoted the development of modern warehousing logistics, commodity supply chain and network freight platform business in an orderly manner. On the day of
, the company also held the st meeting of the 10th board of supervisors, deliberating and passing related reports and proposals such as the company's 2021 annual board of supervisors report. (remaining fruit)
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page